Skip to main content
. 2016 Feb 10;11(2):e0148697. doi: 10.1371/journal.pone.0148697

Table 2. Hazard ratios (HR) of overall cancer and 95% confidence intervals (95% CI) by quartiles (Q) of red blood cell (RBC) folate, serum folate, and dietary folate equivalents (DFE) 1,2, NHANES 1999–2002.

Q1 Q2 Q3 Q4
Red blood cell folate (ng/ml) <237.8 237.8–<318.0 318.0–<422.0 ≥422.0
 Sample size, n 341 361 350 350
 All-cancer cases, n (%) 38 (11.1) 39 (10.3) 27 (7.7) 20 (5.7)
 HR, adjusted (95% CI) 0.98 (0.61–1.57) 1.0 0.68 (0.41–1.14) 0.54 (0.31–0.93)
Serum folate (ng/ml) <10.7 10.7–<15.6 15.6–<22.9 ≥22.9
 Sample size, n 334 350 355 345
 All-cancer cases n (%) 42 (12.6) 32 (9.1) 30 (8.4) 19 (5.5)
 HR, adjusted (95% CI) 1.44 (0.90–2.31) 1.0 0.88 (0.53–1.47) 0.59 (0.33–1.05)
DFE (μg/d) <291.6 291.6–<467.0 467.0–<836.4 ≥836.4
 Sample size, n 345 353 351 338
 All-cancer cases n (%) 31 (9.0) 38 (10.8) 38 (10.8) 18 (5.3)
 HR adjusted, (95% CI) 0.85 (0.51–1.41) 1.0 0.95 (0.60–1.52) 0.54 (0.30–0.95)

1 Tests were performed using Cox proportional hazards regression models that included log-transformed RBC folate, serum folate or DFE

2 Models were adjusted for age, gender, race/ethnicity, educational attainment, smoking status, alcohol intake, physical activity, and BMI. The DFE model was additionally adjusted for total energy intake.